Jóvenes latinos gay ven un porcentaje cada vez mayor de nuevos casos de VIH; piden financiación específica
By Vanessa G. Sánchez and Devna Bose, The Associated Press and Phillip Reese
Un análisis de KFF Health News-Associated Press halló que los hombres latinos homosexuales y bisexuales representan una proporción cada vez mayor de nuevos diagnósticos e infecciones, lo que demuestra que los están dejando atrás en la lucha contra el VIH.
Three-Year Abortion Trends Vary Dramatically by State
By Phillip Reese
About 930,000 abortions occurred in the U.S. in 2020, an 8% increase from 2017. But that nationwide figure belies dramatic variation among states — disparities expected to magnify in the wake of the Supreme Court’s decision to strike down Roe v. Wade.
Why Won’t More Older Americans Get Their Covid Booster?
By Liz Szabo
Approximately 1 in 3 Americans 65 and older who completed their initial vaccination round still have not received a first booster shot. The numbers dismay researchers, who say the lag has cost tens of thousands of lives.
Can Melatonin Gummies Solve Family Bedtime Struggles? Experts Advise Caution
By Jenny Gold
Throughout history, parents have searched for the secret to getting fretful children to sleep through the night. The latest strategy involves giving children melatonin-infused gummies and tablets, a trend that concerns some doctors.
Centene Showers Politicians With Millions as It Courts Contracts and Settles Overbilling Allegations
By Samantha Young and Andy Miller and Rebecca Grapevine
Centene, the largest Medicaid managed-care company in the U.S., has thrown more than $26.9 million at political campaigns across the country since 2015, especially focused on states where it is wooing Medicaid contracts and settling accusations that it overbilled taxpayers. Among its tactics: Centene is skirting contribution limits by giving to candidates through its many subsidiaries.
Newsom’s Big Promises on Drug Prices Are Slow to Materialize
By Angela Hart and Rachel Bluth and Samantha Young
Gov. Gavin Newsom has launched several initiatives to cut rising drug prices, but the savings haven’t been as monumental as he promised. And his plan to have California make its own generic drugs hasn’t gotten off the ground.
